Skip to content

News & Events

Academic GI Cancer Consortium (AGICC)

Explore AGICC

AGICC Home
Institutions & Investigators
About
Facts
Publications

Explore Oncology Consortia

Myeloma (AMyC)
Breast Cancer (ABRCC)
Thoracic Oncology (ATOMIC)
GU Cancer (AURIC)
ASCO Gastrointestinal Cancers Symposium – January 8-10, 2026
We are excited to attend the 2026 ASCO Gastrointestinal Cancers Symposium, held in San Francisco on January 8-10, 2026. Our semi-annual Investigator's Meeting of the Academic GI Cancer Consortium (AGICC)​ will be held on Thursday, January 8th, bringing together AGICC researchers to discuss new developments, collaboration opportunities and potential studies for 2026. 
A University of Colorado Leader Gets a Voice on National Cancer Research Policy
Congratulations to Wells Messersmith, MD, Director of Criterium's Academic GI Cancer Consortium (AGICC) on his appointment to the National Cancer Institute’s Board of Scientific Advisors. 
Criterium’s Oncology Consortia Makes Waves at ASCO 2024 Annual Conference
Dr. Deirdre Cohen and Dr. Robert Lentz, principal investigators with the Academic GI Cancer Consortium, attended the ASCO 2024 Annual Conference and shared valuable insights and progress from their innovative research model and clinical trials.
AGICC Investigator’s Meeting – Investigators Meet at ASCO GI For the First Time Since Covid
AGICC (Academic GI Cancer Consortium) met in person for an Investigator’s Meeting during the recent GI-ASCO 2023 Symposium in San Francisco. This coming year the AGICC group will continue to explore GI oncology trials in partnership with pharmaceutical companies. 
PharmaVoice Interview with Dr. Wells Messersmith, Director of the Academic GI Cancer Consortium (AGICC)
Watch the PharmaVoice One on One video interview below to learn more about the latest in Gastrointestinal Cancer research from Dr. Wells Messersmith, Director of the Academic GI Cancer Consortium and Division Head of Medical Oncology at the University of Colorado Cancer Center.